Christina Ackermann, Director at Verona Pharma plc (VRNA), bought 83,760 shares at $4.74 ($397K) on 2024-11-06, disclosed to the SEC on 2024-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.74 | 41,880 | $199K | 50.0% |
| 2 | $4.74 | 41,880 | $199K | 50.0% |
| Total | $4.74 avg | 83,760 | $397K | 100% |
| Filing → |
| BHC | SELL | 2021-06-04 | $7.7M | — | Filing → |
| BHC | BUY | 2020-03-11 | $160K | — | Filing → |
| BHC | SELL | 2019-08-13 | $153K | — | Filing → |